Literature DB >> 17563278

Injection drug users' strategies to manage perceptions of personal risk: how do IDUs see HIV as having affected them?

Katherine Clegg Smith1, Tiffany Le Lefevre Lillie, Carl Latkin.   

Abstract

The U.S. public health community is in its 3rd decade of seeking to prevent and treat HIV/AIDS. Injection drug users (IDUs) are central to targeted HIV prevention interventions as approximately one third of new U.S. infections are attributable to injection drug use (Santibanez et al.,Journal of Urban Health, 83[1], 86-100, 2006). Targeted behavior change efforts are often explicitly built upon the risk perception of targeted individuals. In this article, we consider the efficacy of behavior change based on IDUs' perceptions of elevated risk. Our qualitative analysis of 28 interviews with HIV negative IDUs in inner city Baltimore suggests that participants did not see themselves as personally affected by HIV. Rather, respondents constructed accounts in which they differentiated themselves from the type of people who are so affected, thereby creating a less stigmatizing identity. We argue that effective HIV prevention should explicitly acknowledge and address the stigmatized IDU identity, rather than assuming readiness for behavior change.

Entities:  

Mesh:

Year:  2007        PMID: 17563278     DOI: 10.1521/aeap.2007.19.3.245

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  2 in total

1.  Understanding low-income, minority older adult self-perceptions of HIV risk.

Authors:  Elijah G Ward; William B Disch; Jean J Schensul; Judith A Levy
Journal:  J Assoc Nurses AIDS Care       Date:  2010-06-26       Impact factor: 1.354

2.  Longitudinal determinants of consistent condom use by partner type among young injection drug users: the role of personal and partner characteristics.

Authors:  F Kapadia; M H Latka; Y Wu; S A Strathdee; M E Mackesy-Amiti; S M Hudson; H Thiede; R S Garfein
Journal:  AIDS Behav       Date:  2009-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.